Frontiers in Cardiovascular Medicine

General Commentary

Published on 27 Feb 2023

Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”

in Cardio-Oncology

Louise Y. Sun
Gift Echefu
Krishna Doshi
Michelle L. Roberts
Abdulaziz Hamid
Richard K. Cheng
Jessica Olson
Sherry-Ann Brown

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.982028

2,058 views
3 citations

Mini Review

Published on 21 Feb 2023

Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal

in Cardio-Oncology

Massimiliano Camilli
Luca Maggio
Lorenzo Tinti
Priscilla Lamendola
Gaetano Antonio Lanza
Filippo Crea
Antonella Lombardo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1090103

4,425 views
16 citations

Review

Published on 17 Feb 2023

Galectin functions in cancer-associated inflammation and thrombosis

in Cardio-Oncology

Linus Kruk
Attila Braun
Erika Cosset
Thomas Gudermann
Elmina Mammadova-Bach

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1052959

8,183 views
13 citations

Case Report

Published on 15 Feb 2023

A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole

in Cardio-Oncology

Yuting Yuan
Chunjian Wang
Hongying Yao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.984572

2,895 views
4 citations

Study Protocol

Published on 10 Feb 2023

Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer–The EARLY-MYO-BC study

in Cardio-Oncology

Yezi Chai
Meng Jiang
Yaohui Wang
Qiming Liu
Qifan Lu
Zhengyu Tao
Qizhen Wu
Wenjin Yin
Jinsong Lu
Jun Pu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1021937

3,747 views
2 citations

Case Report

Published on 09 Feb 2023

Case report: The diagnostic challenge of primary cardiac intimal sarcoma

in Cardio-Oncology

Naili Ye
Lan Lan
Huijuan Hu
Jinping Liu
Haibo Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1089636

3,365 views
6 citations

Original Research

Published on 08 Feb 2023

Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”

in Cardio-Oncology

Dominique J. Monlezun
Andrew Badalamenti
Awad Javaid
Kostas Marmagkiolis
Kevin Honan
Jin Wan Kim
Rishi Patel
Bindu Akhanti
Dan Halperin
Arvind Dasari

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1071138

5,275 views
4 citations

Case Report

Published on 08 Feb 2023

Case report: Persistent ST-segment elevation due to cardiac metastasis from lung cancer

in Cardio-Oncology

Jiawei Zhou
Chengchuang Zhan
Jing Zhou
Chao Wei
Cao Zou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1001527

2,396 views
4 citations

Original Research

Published on 07 Feb 2023

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network

in Cardio-Oncology

Rafael Amorim Belo Nunes
Precil Diego Miranda de Menezes Neves
Leandro Menezes Alves da Costa
Philip Bachour
Marcelo José de Carvalho Cantarelli
Gustavo Bernardes de Figueiredo Oliveira
Álvaro Avezum Jr.

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.888366

5,588 views
1 citation

Original Research

Published on 07 Feb 2023

In-hospital and one-year outcomes in cancer patients receiving percutaneous coronary intervention for acute myocardial infarction: A real-world study

in Cardio-Oncology

Manyun Tang
Yidan Wang
Xiangqi Cao
John D. Day
Hui Liu
Chaofeng Sun
Guoliang Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1005473

2,487 views

Editorial

Published on 01 Feb 2023

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

in Cardio-Oncology

Canan G. Nebigil
Michael W. Y. Chan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1145780

1,131 views
1 citation

Original Research

Published on 25 Jan 2023

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors

in Cardio-Oncology

Zhipeng Wang
Zeyu Fan
Lei Yang
Lifang Liu
Chao Sheng
Fengju Song
Yubei Huang
Kexin Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1014400

5,401 views
27 citations

Original Research

Published on 24 Jan 2023

Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis

in Cardio-Oncology

Efstratios Koutroumpakis
Adam Niku
Christopher K. Black
Abdelrahman Ali
Humaira Sadaf
Juhee Song
Nicolas Palaskas
Cezar Iliescu
Jean-Bernard Durand
Syed Wamique Yusuf

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1073804

1,806 views
4 citations

Original Research

Published on 23 Jan 2023

Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: A single-center prospective clinical study

in Cardio-Oncology

Chuan Zhang
Zhulu Chen
Shu Qin
Yuxi Zhu
Linjie Shu
Zhong Zuo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1052699

3,127 views
12 citations

Correction

Published on 19 Jan 2023

Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

in Cardio-Oncology

Vincenzo Quagliariello
Margherita Passariello
Annabella Di Mauro
Ciro Cipullo
Andrea Paccone
Antonio Barbieri
Giuseppe Palma
Antonio Luciano
Simona Buccolo
Irma Bisceglia

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1129873

1,282 views
5 citations

Original Research

Published on 19 Jan 2023

Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis

in Cardio-Oncology

Hao Jin
Jianfeng Xu
Zheng Sui
Lili Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1101585

3,502 views
6 citations